HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3,9-bis((ethylthio)methyl)-K-252a

RN given for (9S-(9alpha,10beta,12alpha))-isomer; mixed lineage kinase inhibitor, neuroprotective agent, and neurotrophic agent derived from K-252a; structure in first source
Also Known As:
3,9-bis(EtSM)-K-252a; CEP 1347; CEP-1347; CEP1347; KT 7515; KT-7515; KT7515
Networked: 43 relevant articles (2 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Shoulson, Ira: 4 articles (08/2011 - 12/2009)
2. Kitanaka, Chifumi: 3 articles (09/2020 - 11/2017)
3. Okada, Masashi: 3 articles (09/2020 - 11/2017)
4. Sanomachi, Tomomi: 3 articles (09/2020 - 11/2017)
5. Seino, Shizuka: 3 articles (09/2020 - 11/2017)
6. Suzuki, Shuhei: 3 articles (09/2020 - 11/2017)
7. Togashi, Keita: 3 articles (09/2020 - 11/2017)
8. Oakes, David: 3 articles (08/2011 - 12/2009)
9. Lang, Anthony E: 3 articles (03/2011 - 12/2009)
10. Yamamoto, Masahiro: 2 articles (09/2020 - 08/2018)

Related Diseases

1. Ischemia
2. Hypoxia (Hypoxemia)
3. Pancreatitis
4. Parkinson Disease (Parkinson's Disease)
5. Parkinsonian Disorders (Parkinsonism)

Related Drugs and Biologics

1. Ceruletide
2. Tocopherols (Tocopherol)
3. Selegiline (E250)
4. Phosphotransferases (Kinase)
5. Brain-Derived Neurotrophic Factor (BDNF)
6. Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)
7. Uric Acid (Urate)
8. 3,9-bis((ethylthio)methyl)-K-252a
9. JNK Mitogen-Activated Protein Kinases
10. Messenger RNA (mRNA)

Related Therapies and Procedures

1. Therapeutics
2. Intraperitoneal Injections
3. Drug Therapy (Chemotherapy)